Park Vale Capital is an alternative investment firm dedicated to managing assets on behalf of institutions and foundation.
Business Model:
Revenue: $16M
Employees: 51-200
Address: Albion Riverside Building
City: London
State: england
Zip: SW11 4AX
Country: GB
Park Vale Capital is an investment firm that is dedicated to developing and managing fiduciary long term capital in a number of specific, unusual and focused investment strategies. Park Vale advice and provide high-value investment products through direct deal opportunities, funds, and tailor-made investment solutions. Park Vale is built on the pursuit of unusual (low correlation to traditional assets), risk-adjusted positive performance which is designed to drive meaningful out performance in the total asset allocation. Park Vale operate from offices in London, New York, Hong Kong and Shanghai to ensure we are able to source and manage our networks, information and deal flow. Park Vale and it’s partners are experienced professionals with expertise in private equity, Biotechnology, China Special Situations, Real Estate Opportunities, Adaptive Strategies, New Technology, Global Energy, and JABCAP (LUX).
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2017 | Cullinan Oncology | Series A | 150M |
1/2016 | Dearman technologies | Venture Round | 0 |
8/2015 | Causemo | Series A | 0 |
10/2017 | Cullinan Oncology | Series A | 0 |
1/2016 | Dearman technologies | Venture Round | 0 |
8/2015 | Causemo | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|